ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,970.84
-1.11%
Dow Jones
42,992.21
-0.77%
US Dollar vs MXN
20.3272
0.00%
Brent Oil
73.44
0.00%
Bitcoin
94,451.62
0.31%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. bioAffinity Technologies Inc (BIAF)

  7. bioAffinity Technologies Inc (BIAF) Noticias

BIAF

bioAffinity Technologies (BIAF)

bioAffinity Technologies Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BIAF
FechaHoraFuenteTítuloSímboloCompañía
17/12/202407:00Business WireJoin bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19NASDAQ:BIAFbioAffinity Technologies Inc
12/12/202407:00Business WirebioAffinity Technologies Set for Continued Expansion in 2025NASDAQ:BIAFbioAffinity Technologies Inc
05/12/202407:00Business WireVeterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply ScheduleNASDAQ:BIAFbioAffinity Technologies Inc
14/11/202407:00Business WirebioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024NASDAQ:BIAFbioAffinity Technologies Inc
04/11/202407:00Business WirebioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product DevelopmentNASDAQ:BIAFbioAffinity Technologies Inc
30/10/202407:00Business WirebioAffinity Technologies Announces Award of Japanese Patent for CyPath® LungNASDAQ:BIAFbioAffinity Technologies Inc
21/10/202410:39PR Newswire (US)WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
21/10/202409:45Business WirebioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
18/10/202413:57PR Newswire (US)WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
18/10/202411:45Business WirebioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
16/10/202407:00Business WirebioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry GuidelinesNASDAQ:BIAFbioAffinity Technologies Inc
10/10/202407:00Business WirebioAffinity Technologies Names J. Michael Edwards as Chief Financial OfficerNASDAQ:BIAFbioAffinity Technologies Inc
09/10/202407:00Business WirebioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung TestNASDAQ:BIAFbioAffinity Technologies Inc
18/09/202407:00Business WirePeer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and OverdiagnosisNASDAQ:BIAFbioAffinity Technologies Inc
26/08/202407:58IH Market NewsIBM Closes China Research Division, Uber Fined $324M, Starliner to Return Without AstronautsNASDAQ:BIAFbioAffinity Technologies Inc
23/08/202416:17Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BIAFbioAffinity Technologies Inc
23/08/202416:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
23/08/202416:15Business WirebioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFONASDAQ:BIAFbioAffinity Technologies Inc
14/08/202415:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIAFbioAffinity Technologies Inc
14/08/202408:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIAFbioAffinity Technologies Inc
14/08/202408:25Business WirebioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung SalesNASDAQ:BIAFbioAffinity Technologies Inc
12/08/202415:00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BIAFbioAffinity Technologies Inc
05/08/202413:00PR Newswire (US)WallachBeth Capital Announces Closing of bioAffinity Technologies Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionNASDAQ:BIAFbioAffinity Technologies Inc
05/08/202412:17Business WirebioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionNASDAQ:BIAFbioAffinity Technologies Inc
05/08/202408:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
02/08/202409:00PR Newswire (US)WallachBeth Capital Announces bioAffinity Technologies Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionNASDAQ:BIAFbioAffinity Technologies Inc
02/08/202408:25Business WirebioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionNASDAQ:BIAFbioAffinity Technologies Inc
09/07/202407:00Business WirebioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® LungNASDAQ:BIAFbioAffinity Technologies Inc
12/06/202407:00Business WirebioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsNASDAQ:BIAFbioAffinity Technologies Inc
15/05/202408:15Business WirebioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesNASDAQ:BIAFbioAffinity Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:BIAF

Su Consulta Reciente

BIT
TIT
Telecom Italia
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados